Responses
Clinical/translational cancer immunotherapy
Original research
Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion
Compose a Response to This Article
Other responses
No responses have been published for this article.